FDA updates emergency contraceptive consumer label to specify mechanism of action

The FDA has updated the consumer information leaflet for levonorgestrel 1.5 mg, or Plan B One-Step, to specify that this medication is not an abortifacient and will not affect an existing pregnancy.
Plan B One-Step is a 1.5 mg levonorgestrel (Odyssea Pharma) pill taken by mouth following unprotected sex or contraceptive failure. It is available as a nonprescription over-the-counter drug. The medication works by stopping or delaying the release of an egg from the ovary to prevent pregnancy. Currently, the FDA recommends using Plan B One-Step within 72 hours following unprotected sex or

The FDA has updated the consumer information leaflet for levonorgestrel 1.5 mg, or Plan B One-Step, to specify that this medication is not an abortifacient and will not affect an existing pregnancy.
Plan B One-Step is a 1.5 mg levonorgestrel (Odyssea Pharma) pill taken by mouth following unprotected sex or contraceptive failure. It is available as a nonprescription over-the-counter drug. The medication works by stopping or delaying the release of an egg from the ovary to prevent pregnancy. Currently, the FDA recommends using Plan B One-Step within 72 hours following unprotected sex or